H1B Salary Data

Home › Employers › Qazi Makhija & Barney LLP dba Nevada Nephrology Consultants

Qazi Makhija & Barney LLP dba Nevada Nephrology Consultants: H-1B salaries and sponsorship

Qazi Makhija & Barney LLP dba Nevada Nephrology Consultants filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $250,000.

Applications (LCAs)3
Certified3
Employer addressLas Vegas, NV
H-1B dependent employerNo
Median offered salary$250,000
Middle half of salaries$250,000–$250,000
10th–90th percentile$250,000–$250,000

Does Qazi Makhija & Barney LLP dba Nevada Nephrology Consultants sponsor H-1B visas?

Qazi Makhija & Barney LLP dba Nevada Nephrology Consultants filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Jul 21, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Nephrologist3$250,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20253$250,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Nephrologist$250,000
Level I
Las Vegas, NVJul 21, 2025Aug 1, 2025Certified
Nephrologist$250,000
Level I
Las Vegas, NVJul 21, 2025Aug 1, 2025Certified
Nephrologist$250,000
Level I
Las Vegas, NVJul 21, 2025Aug 1, 2025Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).